Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
central nervous system
Pharma
Neurocrine elevates BD chief to succeed founder and CEO
The paucity of commercial-stage neuroscience biotechs has made Neurocrine a regular name on M&A watch lists. Now, the firm has a new CEO.
Angus Liu
May 29, 2024 11:42am
Sanofi calls on 3 drugmakers to market its meds overseas
Mar 27, 2024 9:57am
Takeda, Eisai, GSK and more—Fierce Pharma Asia
Mar 31, 2023 8:27am
Lipocine seeks partner for NASH asset in pivot to oral CNS drugs
Sep 26, 2022 10:50am
Sanofi is offloading 17 meds from its pain and CNS rosters
Jul 12, 2022 9:13am
On a roll, AZ's Ultomiris hits goal in NMOSD
May 5, 2022 10:30am
